The anti-inflammatory effects of d-allose contribute to attenuation of cerebral ischemia-reperfusion injury

Medical Hypotheses

Volumn 76, Issue 6, 2011, Pages 911-913

  Gao, Dakuan ^a,b   Kawai, Nobuyuki ^a   Tamiya, Takashi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOSE; OXYGEN; REACTIVE OXYGEN METABOLITE; RIBOSE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LEUKOCYTE FUNCTION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY;

ANTI-INFLAMMATORY AGENTS; BRAIN; GLUCOSE; HUMANS; REPERFUSION INJURY;

EID: 79955725335     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.007     Document Type: Article

References (40)

1. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with a recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) 1995, 274:1017-1025.
2. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Study Group. N Engl J Med 1995, 333:1581-1587.
3. Kuroiwa T., Shibutani M., Okeda R. Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia. Acta Neuropathol 1988, 76:62-65.
4. Memezawa H., Smith M.L., Siesjö B.K. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992, 23:552-559.
5. Yang G.Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994, 25:1658-1664.
6. Kato H., Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol 1999, 19:93-108.
7. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Metab 2001, 21:2-14.
8. Ozbal S., Erbil G., Koçdor H., Tuǧyan K., Pekçetin C., Ozoǧul C. The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci Lett 2008, 438:265-269.
9. Yousuf S., Atif F., Ahmad M., et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 2009, 1250:242-253.
10. Pozzilli C., Lenzi G.L., Argentino C., et al. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 1985, 16:251-255.
11. Huang Judy, Upadhyay Urvashi M., Tamargo Rafael J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66:232-245.
12. Rodríguez-Yáñez M., Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 2008, 21:353-357.
13. Emsley H.C., Smith C.J., Tyrrell P.J., Hopkins S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care 2008, 9:125-138.
14. DeGraba T.J. The role of inflammation after acute stroke. Utility of pursuing antiadhesion molecule therapy. Neurology 1998, 51:62-68.
15. Rothwell N.J., Busbridge N.J., Lefeuvre R.A., Hardwick A.J., Gauldie J., Hopkins S.J. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol 1991, 69:1465-1469.
16. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003, 62:127-136.
17. Adams D.H., Shaw S. Leukocyte endothelial interactions and regulation of leukocyte migration. Lancet 1994, 343:831-836.
18. Smith C.W. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993, 71:76-87.
19. Vila N., Castillo J., Dávalos A., Chamorro A. Proinflammatory cytokines and early stroke progression. Stroke 2000, 31:2325-2329.
20. Castellanos M., Castillo J., Garci{dotless}́a M.M., et al. Inflammation-mediated damage in progressing lacunar infarctions. Stroke 2002, 33:982-987.
21. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
22. Castellanos M., Leira R., Serena J., et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003, 34:40-46.
23. Hallenbeck J.M., Dutka A.J., Tnihima T., et al. Polymorphonuclear leukocyte accumulation in brain region with low blood flow during the early postischemic period. Stroke 1986, 17:246-253.
24. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992, 23:1367-1379.
25. Harlan J.M. Neutrophil-mediated vascular injury. Acta Med Scand Suppl 1987, 715:123-129.
26. Moncada S., Higgs E.A. Arachidonate metabolism in blood cells and the vessel wall. Clin Haematol 1986, 15:273-292.
27. Weissmann G., Smolen J.E., Korghak H.M. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980, 303:27-34.
28. Barone F.C., Parsons A.A. Therapeutic potential of anti-inflammatory drugs in focal stroke. Expert Opin Investig Drugs 2000, 9:2281-2306.
29. Kanemoto Y., Nakase H., Akita N., Sakaki T. Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model. Neurosurgery 2002, 51:1034-1042.
30. Baker D.C., Horton D., Tindall C.G. Large-scale preparation of d-allose: observations on the sterioselectivity of the reduction of 1, 2: 5, 6-di-O-isopropylidene-α-d-ribo-hexofuranose-3-ulose hydrate. Carbohydr Res 1972, 24:192-197.
31. Bhuiyan S.H., Itami Y., Yuhko R., Katayama T., Izumori K. d-Allose production from d-psicose using immobilized l-rhamnose isomerase. J Ferment Bioeng 1998, 85:540-542.
32. Hossain M.A., Wakabayashi H., Goda F., Kobayashi S., Maeba T., Maeta H. Effect of immunosuppressants FK506 and d-allose on allogenic orthotopic liver transplantation in rats. Transplant Proc 2000, 32:2021-2023.
33. Hossain M.A., Izuishi K., Maeta H. Protective effects of d-allose against ischemia reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 2003, 10:218-225.
34. Hossain M.A., Izuishi K., Tokuda M., Izumori K., Maeta H. d-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase. J Hepatobiliary Pancreat Surg 2004, 11:181-189.
35. Ueki M., Taie S., Chujo K., Asaga T., Iwanaga Y., Maekawa N. Inhibitory effect of d-allose on neutrophil activation after rat renal ischemia/reperfusion. J Biosci Bioeng 2007, 104:304-308.
36. Ueki M., Asaga T., Chujo K., Ono J., Iwanaga Y., Taie S. d-Allose protects against endotoxemic acute renal injury. J Biosci Bioeng 2008, 105:481-485.
37. Murata A., Sekiya K., Watanabe Y., et al. A novel inhibitory effect of d-allose on production of reactive oxygen species from neutrophils. J Biosci Bioeng 2003, 96:89-91.
38. Kimura S., Zhang G.X., Nishiyama A., et al. d-allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats. J Hypertens 2005, 23:1887-1894.
39. Hirooka K., Miyamoto O., Jinming P., et al. Neuroprotective effects of d-allose against retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2006, 47:1653-1657.
40. Nakamura T., Tanaka S., Hirooka K., et al. Anti-oxidative effects of d-allose, a rare sugar, on ischemia-reperfusion damage following focal cerebral ischemia in rat. Neurosci Lett 2011, 487:103-106.